Literature DB >> 8600321

Neutrophil apoptosis induced by proteolytic enzymes.

A S Trevani1, G Andonegui, M Giordano, M Nociari, P Fontán, G Dran, J R Geffner.   

Abstract

In this study, we show that three proteolytic enzymes of different specificity-pronase, chymotrypsin, and trypsin-induced a dramatic stimulation of neutrophil apoptosis as shown by morphologic characteristics, analysis of cell DNA content, and presence of a characteristic "ladder" pattern of DNA fragmentation. The action of either chymotrypsin or trypsin was completely prevented by the serine protease inhibitor aprotinin, indicating that the proteolytic activity of the enzymes accounts for apoptosis induction. Stimulation of neutrophil apoptosis by proteases was observed in culture medium supplemented with either inactivated fetal calf serum (0.1-50%), autologous serum (0.1-50%), bovine serum albumin (0.1%), or in protein-free medium. Other cell types such as human peripheral blood monocytes and lymphocytes, human leukemic cells from THP-1, HL-60 and K562 lines, murine L929 fibroblasts, and unstimulated murine macrophages harvested from the peritoneal cavity were not induced to undergo apoptosis after the treatment with proteases. In an attempt to determine whether neutrophil serine proteases could induce apoptosis as chymotrypsin and trypsin do, the effect of elastase was assessed. A significant increase in the percentage of apoptotic cells was observed in elastase-treated neutrophils. We propose that the selective stimulation of neutrophil apoptosis by proteolytic enzymes may play an important role in the normal resolution of inflammation by limiting the autotoxic potential of the neutrophil.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8600321

Source DB:  PubMed          Journal:  Lab Invest        ISSN: 0023-6837            Impact factor:   5.662


  8 in total

1.  Alkaline conditions accelerate polymorphonuclear leukocyte apoptosis in vitro.

Authors:  B Leblebicioglu; J Walters
Journal:  Infect Immun       Date:  1999-04       Impact factor: 3.441

2.  Streptococcal pyrogenic exotoxin B-induced apoptosis in a549 cells is mediated by a receptor- and mitochondrion-dependent pathway.

Authors:  Wan-Hua Tsai; Chia-Wen Chang; Woei-Jer Chuang; Yee-Shin Lin; Jiunn-Jong Wu; Ching-Chuan Liu; Wen-Tsan Chang; Ming T Lin
Journal:  Infect Immun       Date:  2004-12       Impact factor: 3.441

3.  Alpha-1 antitrypsin deficiency alleles and severe cystic fibrosis lung disease.

Authors:  R Mahadeva; S Stewart; D Bilton; D A Lomas
Journal:  Thorax       Date:  1998-12       Impact factor: 9.139

4.  Analysis of the mechanisms involved in the stimulation of neutrophil apoptosis by tumour necrosis factor-alpha.

Authors:  Gabriela Salamone; Analía Trevani; Diego Martínez; Mónica Vermeulen; Romina Gamberale; Paula Fernández-Calotti; Silvina Raiden; Mirta Giordano; Jorge Geffner
Journal:  Immunology       Date:  2004-11       Impact factor: 7.397

5.  Genetic ablation of Nrf2 enhances susceptibility to cigarette smoke-induced emphysema in mice.

Authors:  Tirumalai Rangasamy; Chung Y Cho; Rajesh K Thimmulappa; Lijie Zhen; Sorachai S Srisuma; Thomas W Kensler; Masayuki Yamamoto; Irina Petrache; Rubin M Tuder; Shyam Biswal
Journal:  J Clin Invest       Date:  2004-11       Impact factor: 14.808

Review 6.  Mediation of Cardiac Macrophage Activity via Auricular Vagal Nerve Stimulation Ameliorates Cardiac Ischemia/Reperfusion Injury.

Authors:  Chee Hooi Chung; Beatrice Bretherton; Satirah Zainalabidin; Susan A Deuchars; Jim Deuchars; Mohd Kaisan Mahadi
Journal:  Front Neurosci       Date:  2020-09-08       Impact factor: 4.677

7.  Effect of some clinically used proteolytic enzymes on inflammation in rats.

Authors:  A H M Viswanatha Swamy; P A Patil
Journal:  Indian J Pharm Sci       Date:  2008-01       Impact factor: 0.975

8.  Alpha-Chymotrypsin Protects Against Acute Lung, Kidney, and Liver Injuries and Increases Survival in CLP-Induced Sepsis in Rats Through Inhibition of TLR4/NF-κB Pathway.

Authors:  Shaymaa Ramzy Senousy; Al-Shaimaa F Ahmed; Dalia A Abdelhafeez; Mohamed Montaser A Khalifa; Mohammed A S Abourehab; Mahmoud El-Daly
Journal:  Drug Des Devel Ther       Date:  2022-09-08       Impact factor: 4.319

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.